NCT05870241 (PM) is a NA clinical trial of Ga-As Laser in Post Mastectomy Lymphedema, sponsored by Cairo University.

Who is sponsoring NCT05870241?

NCT05870241 is sponsored by Cairo University.

What drugs are being tested in NCT05870241?

Interventions in NCT05870241: Ga-As Laser, Microcurrent Electrical Stimulation, traditional therapy.

What condition does NCT05870241 study?

NCT05870241 studies Post Mastectomy Lymphedema.

Is NCT05870241 still recruiting?

NCT05870241 is currently completed. Last updated 24 October 2023.

Last reviewed 2023-10-24 · How we verify

NCT05870241: PM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Post-Mastectomy Shoulder Pain And Lymphedema Responses To Ga-As Laser Versus Microcurrent Electrical Stimulation

Completed NA Last updated 24 October 2023

What this trial tests

NA trial testing Ga-As Laser in Post Mastectomy Lymphedema in 60 participants. Completed in 30 September 2023.

Timeline

25 May 2023

Primary endpoint
30 September 2023

30 September 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	25 May 2023
Primary completion	30 September 2023
Estimated completion	30 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

Ga-As Laser
Microcurrent Electrical Stimulation
traditional therapy — full drug profile →

Conditions studied

Post Mastectomy Lymphedema — all drugs for Post Mastectomy Lymphedema →

Sponsor

Cairo University

Who can join

Adults 40 to 55, female only, with Post Mastectomy Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of this study is to investigate the effect of GA-AS laser versus microcurrent on post-mastectomy shoulder pain and lymphedema.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications.
Li K, Guo B, Gu J, Ta N, et al · · 2025 · cited 8× · PMID 39759851 · DOI 10.1016/j.mtbio.2024.101375

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05870241 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 24 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05870241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing